Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

734 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fatigue in early multiple sclerosis: MRI metrics of neuroinflammation, relapse and neurodegeneration.
Meijboom R, Foley P, MacDougall NJJ, Mina Y, York EN, Kampaite A, Mollison D, Kearns PKA, White N, Thrippleton MJ, Murray K, Valdés Hernández MDC, Reich DS, Connick P, Jacobson S, Nair G, Chandran S, Waldman AD. Meijboom R, et al. Among authors: foley p. Brain Commun. 2024 Aug 14;6(5):fcae278. doi: 10.1093/braincomms/fcae278. eCollection 2024. Brain Commun. 2024. PMID: 39386090 Free PMC article.
FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosis.
Kearns PKA, Martin SJ, Chang J, Meijboom R, York EN, Chen Y, Weaver C, Stenson A, Hafezi K, Thomson S, Freyer E, Murphy L, Harroud A, Foley P, Hunt D, McLeod M, O'Riordan J, Carod-Artal FJ, MacDougall NJJ, Baranzini SE, Waldman AD, Connick P, Chandran S. Kearns PKA, et al. Among authors: foley p. BMJ Open. 2022 Jun 29;12(6):e058506. doi: 10.1136/bmjopen-2021-058506. BMJ Open. 2022. PMID: 35768080 Free PMC article.
Network analysis characterizes key associations between subjective fatigue and specific depressive symptoms in early relapsing-remitting multiple sclerosis.
Chang YT, Kearns PKA, Carson A, Gillespie DC, Meijboom R, Kampaite A, Valdés Hernández MDC, Weaver C, Stenson A, MacDougall N, O'Riordan J, Macleod MA, Carod-Artal FJ, Connick P, Waldman AD, Chandran S, Foley P. Chang YT, et al. Among authors: foley p. Mult Scler Relat Disord. 2023 Jan;69:104429. doi: 10.1016/j.msard.2022.104429. Epub 2022 Nov 24. Mult Scler Relat Disord. 2023. PMID: 36493562 Free article.
Efficacy of Fluoxetine, Riluzole and Amiloride in treating neuropathic pain associated with secondary progressive multiple sclerosis. Pre-specified analysis of the MS-SMART double-blind randomised placebo-controlled trial.
Foley P, Parker RA, de Angelis F, Connick P, Chandran S, Young C, Weir CJ, Chataway J; MS-SMART Investigators. Foley P, et al. Mult Scler Relat Disord. 2022 Jul;63:103925. doi: 10.1016/j.msard.2022.103925. Epub 2022 May 28. Mult Scler Relat Disord. 2022. PMID: 35671671 Free article. Clinical Trial.
Outcome after conservative management or intervention for unruptured brain arteriovenous malformations.
Al-Shahi Salman R, White PM, Counsell CE, du Plessis J, van Beijnum J, Josephson CB, Wilkinson T, Wedderburn CJ, Chandy Z, St George EJ, Sellar RJ, Warlow CP; Scottish Audit of Intracranial Vascular Malformations Collaborators. Al-Shahi Salman R, et al. JAMA. 2014 Apr 23-30;311(16):1661-9. doi: 10.1001/jama.2014.3200. JAMA. 2014. PMID: 24756516 Free article.
734 results